Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1
2007; Taylor & Francis; Volume: 48; Issue: 9 Linguagem: Inglês
10.1080/10428190701509806
ISSN1042-8194
AutoresAndrea Alonci, Alessandro Allegra, Giacomo Bellomo, Eugenia Quartarone, Giacomo Oteri, Enrico Nastro Siniscalchi, D Cicciù, Francesco Saverio De Ponte, Caterina Musolino,
Tópico(s)Bone Tumor Diagnosis and Treatments
ResumoIn an article recently published in Leukemia and Lymphoma, Pozzi et al. reported 35 cases of bisphosphonate-associated osteonecrosis of the jaw (ONJ) in multiple myeloma patients [1]. In fact, sinc...
Referência(s)